Results 261 to 270 of about 8,715,620 (378)

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Streamlining a Patchwork - Exploring the Challenges of Digital Transformation in Pathology: Ethnographic Study.

J Med Internet Res
Geisler BL, Amperidou O, Pauly SP, Mattern S, Schürch CM, Hermann C, Stoffregen C, Steinleitner I, Paigin N, Lamß C, Fend F, Rieger MA, Rind E, Preiser C.   +13 more
europepmc   +1 more source

Correction: Exploration of the relationship between Graves' eye disease and type 2 diabetes based on biomarkers. [PDF]

Hormones (Athens)
Guan Y, Fan M, Ren X, Zhang S, Cao C, Lan J, Cao Q, Zhang T, Xu F, Zhang T.   +9 more
europepmc   +1 more source

The living of the diagnosis and the initial therapeutic phase by people with cancer pathologies : what roles for general practice in the context of social inequalities in health?

, 2019
Guillaume Coindard
openalex   +1 more source

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source

Spontaneous mammalian models for Alzheimer's disease and dementia. [PDF]

Brain Commun
Ford M, Gunn-Moore FJ, Dagleish MP.
europepmc   +1 more source

Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis

Arthritis Care &Research, Accepted Article.
Background Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical. Therefore, we analyzed data from our
Shivani Garg, Brad Rovin, Brad C. Astor, Tripti Singh, Fauzia Hollnagel, Megan Kuik, Lexie Kolton, Callie Saric, S. Sam Lim, Christie M. Bartels   +9 more
wiley   +1 more source

Pediatric Implant of a Gold-Coated Defibrillator due to Persistent Metal Hypersensitivity: Case Report. [PDF]

Ann Noninvasive Electrocardiol
Duarte-Sau MJ, Arzola-Hernández JC, Gutiérrez-García AH, Castro-Rodríguez A, Rosales-Mendoza D.   +4 more
europepmc   +1 more source